medigraphic.com
ISSN 2007-1523 (Electronic)
Revista Mexicana de Trastornos Alimentarios

2017, Number 2

<< Back Next >>

Revista Mexicana de Trastornos Alimentarios 2017; 8 (2)

Polycystic ovarian syndrome and its potential association with bipolar disorder in patients with eating disorder

Rodríguez GM, Gempeler RJ, Pérez MV, Ribero SO

Language: Spanish
References: 65
Page: 142-150
PDF size: 401.48 Kb.


ABSTRACT

Exploration of polycystic ovarian syndrome (PCOS) in women with eating disorders (ED) is uncommon, and its association with bipolar disorder (BD) has been understudied. The aim of this study was to determine the prevalence of PCOS in women with ED in an outpatient program and to analyze the potential associations with BD. A total of 388 patients (88 with PCOS and 300 without PCOS) aged among 14 to 61 years were included in the study. Pelvic ultrasound, laboratory tests, and physical exams were performed to each participant. Bivariate analyses were carried out between PCOS, BD and other variables such as: psychiatric comorbidities, body mass index and type of ED. An association model was built. PCOS and BD prevalence were 22.7% and 13.1% respectively. The variables associated with PCOS were: BD type II, overweight or obesity and having an ED with binges and/or purges. When obesity and bulimic ED subtypes were controlled, patients with PCOS and BD type have 5.8 times higher risk of BD type II (OR = 5.85; 95% IC = 2.9-11.6). Comorbidities among these three pathologies are frequent, therefore its exploration and management should be considered.


REFERENCES

  1. Annagür, B. B., Kerimoglu, O. S., Tazegül, A., Gündüz, S. yGenc¸oglu, B. B. (2015). Psychiatric comorbidity in womenwith polycystic ovary syndrome. Journal of Obstetrics andGynaecology Research, 41(8), 1229---1233. http://dx.doi.org/10.1111/jog.12696

  2. Asociación Psiquiátrica Americana. (2002). Manual diagnóstico yestadístico de los trastornos mentales: DSM-IV-TR. Espa˜na: Mas-son.

  3. Azziz, R. (2006). Diagnosis of polycystic ovarian syndrome: TheRotterdam Criteria are premature. Journal of Clinical Endo-crinology and Metabolism, 91(3), 781---785. http://dx.doi.org/10.1210/jc.2005-2153

  4. Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E.S. y Yildiz, B. O. (2004). The prevalence and features of thepolycystic ovary syndrome in an unselected population. Jour-nal of Clinical Endocrinology and Metabolism, 89(6), 2745---2749.http://dx.doi.org/10.1210/jc.2003-032046

  5. Barbosa, I. G., Bauer, M. E., Machado-Vieira, R. y Texeira,A. L. (2014). Cytokines in bipolar disorder: Paving the wayfor neuroprogression. Neural Plasticity, http://dx.doi.org/10.1155/2014/360481

  6. Bishop, S. C., Basch, S. y Futterweitt, W. (2009). Polycystic ovarysyndrome, depression, and affective disorders. Endocrine Prac-tice, 15(5), 475---482. http://dx.doi.org/10.4158/EP09083.RAR

  7. Blay, S. L., Aguiar, J. V. A. y Passos, I. C. (2016). Polycystic ovarysyndrome and mental disorders: A systematic review and explo-ratory meta-analysis. Neuropsychiatric Disease and Treatment,12, 2895---2903. http://dx.doi.org/10.2147/NDT.S91700

  8. Campos, R. N., Angst, J., Cordas, T. A. y Moreno, R. A.(2011). ESPECTRA: Searching the bipolar spectrum in eatingdisorder patients. BMC Psychiatry, 11, e-59. http://dx.doi.org/10.1186/1471-244X-11-59

  9. Cesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou,A. N. y Landén, M. (2016). Polycystic ovary syndrome andpsychiatric disorders: Co-morbidity and heritability in a nation-wide Swedish cohort. Psychoneuroendocrinology, 73, 196---203.http://dx.doi.org/10.1016/j.psyneuen.2016.08.005

  10. Davari-Tanha, F., Hosseini, B., Ghajarzadeh, M. y Noorbala, A. A.(2014). Bipolar disorder in women with polycystic ovarian syn-drome (PCO). Acta Medica Iranica, 52(1), 46---48.

  11. Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C.,Laven, J. S. y Legro, R. S. (2015). Scientific statement on thediagnostic criteria, epidemiology, pathophysiology, and molecu-lar genetics of polycystic ovary syndrome. Endocrine Reviews,36(5), 487---525. http://dx.doi.org/10.1210/er.2015-1018

  12. El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G. y Daoud, G.(2016). Poly cystic ovarian syndrome: An updated overview.Frontiers in Physiology, 7, e-124. http://dx.doi.org/10.3389/fphys.2016.00124

  13. Farrell, K. y Antoni, M. H. (2011). Insulin resistance, obe-sity, inflammation, and depression in polycystic ovarysyndrome: Biobehavioral mechanisms and interventions.Modern Trends, 94(5), 1565---1574. http://dx.doi.org/10.1016/j.fertnstert.2010.03.081

  14. Fornaro, M., Perugi, G., Gabrielli, F., Prestia, D., Mattei, C.,Vinciguerra, V., et al. (2010). Lifetime co-morbidity with diffe-rent subtypes of eating disorders in 148 females with bipolardisorders. Journal of Affective Disorders, 121(1), 147---151.http://dx.doi.org/10.1016/j.jad.2009.06.007

  15. Genton, P., Bauer, I., Duncan, S., Taylor, A. E., Balen, A. H.,Eberle, A., et al. (2001). On association between valproateand polycystic ovary syndrome. Epilepsia, 42(3), 295---304.http://dx.doi.org/10.1046/j.1528-1157.2001.28899.x

  16. Goldstein, B. I., Lotrich, F., Axelson, D. A., Gill, M. K., Hower,H., Goldstein, T. R., et al. (2015). Inflammatory markersamong adolescents and young adults with bipolar spectrumdisorders. Journal of Clinical Psychiatry, 76(11), 1556---1563.http://dx.doi.org/10.4088/JCP.14m09395

  17. Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G. y Azziz,R. (2011). Polycystic ovary syndrome: Etiology, pathogenesisand diagnosis. Nature Review Endocrinology, 7(4), 219---231.http://dx.doi.org/10.4088/JCP.14m09395

  18. Goodarzi, M. O. y Korenman, S. G. (2003). The importance of insulinresistance in polycystic ovary syndrome. Fertility and Sterility,80(2), 255---258. http://dx.doi.org/10.1210/edrv.18.6.0318

  19. Himelein, M. J. y Thatcher, S. S. (2006). Polycystic ovarysyndrome and mental health: A review. Obstetrical and Gyne-cological Survey, 61(11), 723---732. http://dx.doi.org/10.1097/01.ogx.0000243772.33357.84

  20. Hirschberg, A. L., Naessén, S., Stridsberg, M., Byström, B. y Holte,J. (2004). Impaired cholecystokinin secretion and disturbedappetite regulation in women with polycystic ovary syndrome.Gynecological Endocrinology, 19(2), 79---87.

  21. Hollinrake, E., Abreu, A., Maifeld, M., van Voorhis, B. J.y Dokras, A. (2007). Increased risk of depressive disor-ders in women with polycystic ovary syndrome. Fertilityand Sterility, 87(6), 1369---1376. http://dx.doi.org/10.1016/j.fertnstert.2006.11.039

  22. Hung, J., Hu, L., Tsai, S., Yang, A. C., Huang, M., Chen,P., et al. (2014). Risk of psychiatric disorders followingpolycystic ovary syndrome: A nationwide population-basedcohort study. Plos One, 9(5), 7---12. http://dx.doi.org/10.1371/journal.pone.0097041

  23. Hussain, A., Chandel, R. K., Ganie, M. A., Dar, M. A., Rather, Y.H., Wani, Z. A., et al. (2015). Prevalence of psychiatric disor-ders in patients with a diagnosis of polycystic ovary syndrome inKashmir. Indian Journal of Psychological Medicine, 37(1), 66---70.http://dx.doi.org/10.4103/0253-7176.150822

  24. Jahanfar, S., Eden, J. A. y Nguyent, T. V. (1995). Bulimia nervosa andpolycystic ovary syndrome. Gynecological Endocrinology, 9(2),113---117.

  25. Jahanfar, S., Maleki, H. y Mosavi, A. R. (2005). Subclinical eatingdisorder, polycystic ovary syndrome- is there any connection bet-ween these two conditions through leptin- a twin study. MedicalJournal of Malaysia, 60(3), 441---446.

  26. Jiang, B., Kenna, H. A. y Rasgon, N. L. (2009). Geneticoverlap between polycystic ovary syndrome and bipolar disor-der: The endophenotype hypothesis. Medical Hypotheses,73(6), 996---1004. http://dx.doi.org/10.1016/j.mehy.2008.12.056

  27. Kemp, D. E., Gao, K., Chan, P., Ganocy, S. J., Findling, R. L. yCalabrese, J. R. (2010). Medical comorbidity in bipolar disor-der: Relationship between illnesses of the endocrine/metabolicsystem and treatment outcome. Bipolar Disorders, 12(4),404---413. http://dx.doi.org/10.1111/j.1399-5618.2010.00823.x

  28. Kerchner, A., Lester, W., Stuart, S. P. y Dokras, A. (2009). Riskof depression and other mental health disorders in womenwith polycystic ovary syndrome: A longitudinal study. Ferti-lity and Sterility, 91(1), 207---212. http://dx.doi.org/10.1016/j.fertnstert.2007.11.022

  29. Kimmel, M. C., Ferguson, E. H., Zerwas, S., Bulik, C. M. y Meltzer-Brody, S. (2016). Obstetric and gynecologic problems associatedwith eating disorders. International Journal of Eating Disorders,49(3), 260---275. http://dx.doi.org/10.1002/eat.22483

  30. Klipstein, K. G. y Goldberg, J. F. (2006). Screening for bipo-lar disorder in women with polycystic ovary syndrome: Apilot study. Journal of Affective Disorders, 91(2-3), 205---209.http://dx.doi.org/10.1016/j.jad.2006.01.011

  31. Kousta, E., Tolis, G. y Franks, S. (2005). Polycystic ovary syndrome:Revised diagnostic criteria and long-term health consequen-ces. Hormones, 4(3), 133---147. http://dx.doi.org/10.1016/j.jad.2006.01.011

  32. Krepuła, K., Bidzi´nska-Speichert, B., Lenarcik, A. y Tworowska-Bardzi´nska, U. (2012). Psychiatric disorders related to polycysticovary syndrome. Endokrynologia Polska, 63(6), 488---491.

  33. Kyrou, I., Weickert, M. O. y Randeva, H. S. (2015). Diagnosisand management of polycystic ovary syndrome (PCOS). En R.Ajjan y S. M. Orme (Eds.), Endocrinology and diabetes: Casestudies, questions and commentaries (pp. 99---113). Londres:Springer.

  34. Liu, X., & Bipolar Genome Study (BiGS)., Kelsoe, J. R. y Green-wood, T. A. (2016). A genome- wide association study ofbipolar disorder with comorbid eating disorder replicates theSOX2-OT region. Journal of Affective Disorders, 189, 141---149.http://dx.doi.org/10.1016/j.jad.2015.09.029

  35. Livadas, S., Chaskou, S., Kandaraki, A. A., Skourletos, G., Eco-nomou, F., Christou, M., et al. (2011). Anxiety is associatedwith hormonal and metabolic profile in women with polycys-tic ovarian syndrome. Clinical Endocrinology, 75(5), 698---703.http://dx.doi.org/10.1111/j.1365-2265.2011.04122.x

  36. Lunde, A. V., Fasmer, O. B., Akiskal, K. K., Akiskal, H. S. yOedegaard, K. J. (2009). The relationship of bulimia and ano-rexia nervosa with bipolar disorder and its temperamentalfoundations. Journal of Affective Disorders, 115(3), 309---314.http://dx.doi.org/10.1016/j.jad.2008.10.012

  37. Månsson, M., Holte, J., Landin-Wilhelmsen, K., Dahlgren, E.,Johansson, A. y Landén, M. (2008). Women with polycys-tic ovary syndrome are often depressed or anxious: A casecontrol study. Psychoneuroendocrinology, 33(8), 1132---1138.http://dx.doi.org/10.1016/j.psyneuen.2008.06.003

  38. March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I., Nor-man, R. J. y Davies, M. J. (2010). The prevalence of polycysticovary syndrome in a community sample assessed under contras-ting diagnostic criteria. Human Reproduction, 25(2), 544---551.http://dx.doi.org/10.1093/humrep/dep399

  39. McCluskey, S., Evans, C., Lacey, J. H., Pearce, J. M. y Jacobs,H. (1991). Polycystic ovary syndrome and bulimia. Ferti-lity and Sterility, 55(2), 287---291. http://dx.doi.org/10.1016/S0015-0282(16)54117-X

  40. McCluskey, S., Lacey, J. H. y Pearce, J. M. (1992). Bingeeating and polycystic ovaries. Lancet, 340(8821), 723---724.http://dx.doi.org/10.1016/0140-6736(92)92257-G

  41. McElroy, S. L., Crow, S., Biernacka, J. M., Winham, S.,Geske, J., Cuellar, A. B., et al. (2013). Clinical phe-notype of bipolar disorder with comorbid binge eatingdisorder. Journal of Affective Disorders, 150(3), 981---986.http://dx.doi.org/10.1016/j.jad.2013.05.024

  42. McElroy, S. L., Kotwal, R. y Keck, P. E. (2006). Comorbidityof eating disorders with bipolar disorder and treat-ment implications. Bipolar Disorders, 8(6), 686---695.http://dx.doi.org/10.1111/j.1399-5618.2006.00401.x

  43. McElroy, S. L., Kotwal, R., Keck, P. E. y Akiskal, H. S.(2005). Comorbidity of bipolar and eating disorders: Dis-tinct or related disorders with shared dysregulations? Journalof Affective Disorders, 86(2-3), 107---127. http://dx.doi.org/10.1016/j.jad.2004.11.008

  44. McIntyre, R. S., Mancini, D. A., McCann, S., Srinivasan, J. y Kennedy,S. H. (2005). Valproate, bipolar disorder and polycystic ovariansyndrome. Bipolar Disorders, 5(1), 28---35.

  45. Michelmore, K. F., Balen, A. H. y Dunger, D. B. (2001). Polycysticovaries and eating disorders: Are they related? Human Repro-duction, 16(4), 765---769.

  46. Morgan, J. F., McCluskey, S. E., Brunton, J. N. y Lacey, H.(2002). Polycystic ovarian morphology and bulimia nervosa: A9-year follow-up study. Fertility and Sterility, 77(5), 928---931.http://dx.doi.org/10.1016/S0015-0282(02)03063-7

  47. Morgan, J., Scholtz, S., Lacey, H. y Conway, G. (2008). The preva-lence of eating disorders in women with facial hirsutism: An epi-demiological cohort study. International Journal of Eating Disor-ders, 41(5), 427---431. http://dx.doi.org/10.1002/eat.20527

  48. Muneer, A. (2016a). Bipolar disorder: Role of inflammation and thedevelopment of disease biomarkers. Psychiatry Investigation,13(1), 18---33. http://dx.doi.org/10.4306/pi.2016.13.1.18

  49. Muneer, A. (2016b). Staging models in bipolar disorder: Asystematic review of the literature. Clinical Psychopharma-cology and Neuroscience, 14(2), 117---130. http://dx.doi.org/10.9758/cpn.2016.14.2.117

  50. Muneer, A. (2016c). The neurobiology of bipolar disorder: Anintegrated approach. Chonnam Medical Journal, 52(1), 18---37.http://dx.doi.org/10.4068/cmj.2016.52.1.18

  51. Nair, M. K., Pappachan, P., Balakrishnan, S., Leena, M. L., George,B. y Russell, P. S. (2012). Menstrual irregularity and poly-cystic ovarian syndrome among adolescent girls: A 2 yearfollow-up study. Indian Journal of Pediatrics, 79(1), 69---73.http://dx.doi.org/10.1007/s12098-011-0432-y

  52. O’Donovan, C., Kusumakar, V., Graves, G. R. y Bird, D. C.(2002). Menstrual abnormalities and polycystic ovary syndromein women taking valproate for bipolar mood disorder. JournalClinical Psychiatry, 63(4), 322---330.

  53. Okanovi´c, M. yˇZivanovi´c, O. (2016). Valproate, bipolar disorderand polycystic ovarian syndrome. Medicinski Pregled, 69(3-4),121---126.

  54. Raphael, F. J., Rodin, D. A., Peattie, A., Bano, G., Kent, A., Nussey,S. S., et al. (1995). Ovarian morphology and insulin sensitivityin women with bulimia nervosa. Clinical Endocrinology, 43(4),451---455.

  55. Rasgon, N. L., Altshuler, L. L., Fairbanks, L., Elman, S.,Bitran, J., Labarca, R., et al. (2005). Reproductive functionand risk for PCOS in women treated for bipolar disor-der. Bipolar Disorders, 7(3), 246---259. http://dx.doi.org/10.1111/j.1399-5618.2005.00201.x

  56. Rassi, A., Veras, A. B., dos Reis, M., Pastore, D. L., Bruno,L. M., Bruno, R. V., et al. (2010). Prevalence of psy-chiatric disorders in patients with polycystic ovarysyndrome. Comprehensive Psychiatry, 51(6), 599---602.http://dx.doi.org/10.1016/j.comppsych.2010.02.009

  57. Rodríguez, M. B. (2006). Associated variables with bipolar disorderrisk in a sample of Colombian women with eating disor-ders. European Eating Disorders Review, 14(4), 242---247.http://dx.doi.org/10.1002/erv.727

  58. Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003consensus on diagnostic criteria and long-term health risks rela-ted to polycystic ovary syndrome. Fertility and Sterility, 81(1),19---25. http://dx.doi.org/10.1016/j.fertnstert.2003.10.004

  59. Scaruffi, E., Gambineri, A., Cattaneo, S., Turra, J., Vettor, R. yMioni, R. (2014). Personality and psychiatric disorders in womenaffected by polycystic ovary syndrome. Frontiers in Endocrino-logy, 5(185), 1---8. http://dx.doi.org/10.3389/fendo.2014.00185

  60. Seixas, C., Miranda-Scippa, Â., Nery-Fernandes, F., Andrade-Nascimento, M., Quarantini, L., Kapczinski, F., et al. (2012).Prevalence and clinical impact of eating disorders in bipo-lar patients. Revista Brasileira de Psiquiatría, 34(1), 66---70.http://dx.doi.org/10.1590/S1516-44462012000100012

  61. Sirmans, S. M. y Pate, K. A. (2014). Epidemiology, diagnosis, andmanagement of polycystic ovary syndrome. Clinical Epidemio-logy, 6(1), 1---13. http://dx.doi.org/10.2147/CLEP.S37559

  62. Tehrani, F. R., Simbar, M., Tohidi, M., Hosseinpanah, F. y Azizi,F. (2011). The prevalence of polycystic ovary syndrome in acommunity sample of Iranian population: Iranian PCOS preva-lence study. Reproductive Biology and Endocrinology, 9, e-39.http://dx.doi.org/10.1186/1477-7827-9-39

  63. Tseng, M. M., Chang, C., Chen, K., Liao, S. y Chen, H. (2016).Prevalence and correlates of bipolar disorders in patients witheating disorders. Journal of Affective Disorders, 190, 599---606.http://dx.doi.org/10.1016/j.jad.2015.10.062

  64. Wildes, J. E., Marcus, M. D. y Fagiolini, A. (2007). Eatingdisorders and illness burden in patients with bipolar spec-trum disorders. Comprehensive Psychiatry, 48(6), 516---521.http://dx.doi.org/10.1016/j.comppsych.2007.05.012

  65. Zawadski, J. K. y Dunaif, A. (1992). Diagnostic criteria for polycys-tic ovary syndrome: Towards a rational approach. En A. Dunaif,J. R. Givens, F. P. Haseltine, y G. R. Merriam (Eds.), Polycys-tic ovary syndrome (pp. 377---384). Boston: Blackwell ScientificPublications.




2020     |     www.medigraphic.com